The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Botulinum Toxin Type A-Global Market Insights and Sales Trends 2024
Synopsis
Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products: 50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.
The global Botulinum Toxin Type A market size is expected to reach US$ 8335.1 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Botulinum Toxin Type A in various end use industries. The expanding demands from the Cosmetic Applications, Therapeutic Applications and Others,, are propelling Botulinum Toxin Type A market. 50 Units, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 100 Units segment is estimated at % CAGR for the next seven-year period.
Global Botulinum Toxin A key players include Allergan (AGN), Ipsen, Merz Pharmaceuticals, etc.
United States is the largest market, with a share about 75%, followed by China, and Europe, both have a share about 20 percent.
In terms of product, 50iu is the largest segment, with a share about 60%. And in terms of application, the largest application is Medical Use, followed by Beauty Use.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Botulinum Toxin Type A, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Botulinum Toxin Type A market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Botulinum Toxin Type A market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Botulinum Toxin Type A sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Botulinum Toxin Type A covered in this report include ALLERGAN, Galderma, Merz Pharma, DAEWOONG, Ipsen and Pfizer, etc.
The global Botulinum Toxin Type A market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ALLERGAN
Galderma
Merz Pharma
DAEWOONG
Ipsen
Pfizer
Global Botulinum Toxin Type A market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Botulinum Toxin Type A market, Segment by Type:
50 Units
100 Units
200 Units
Global Botulinum Toxin Type A market, by Application
Cosmetic Applications
Therapeutic Applications
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Botulinum Toxin Type A manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Botulinum Toxin Type A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products: 50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.
The global Botulinum Toxin Type A market size is expected to reach US$ 8335.1 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Botulinum Toxin Type A in various end use industries. The expanding demands from the Cosmetic Applications, Therapeutic Applications and Others,, are propelling Botulinum Toxin Type A market. 50 Units, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 100 Units segment is estimated at % CAGR for the next seven-year period.
Global Botulinum Toxin A key players include Allergan (AGN), Ipsen, Merz Pharmaceuticals, etc.
United States is the largest market, with a share about 75%, followed by China, and Europe, both have a share about 20 percent.
In terms of product, 50iu is the largest segment, with a share about 60%. And in terms of application, the largest application is Medical Use, followed by Beauty Use.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Botulinum Toxin Type A, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Botulinum Toxin Type A market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Botulinum Toxin Type A market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Botulinum Toxin Type A sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Botulinum Toxin Type A covered in this report include ALLERGAN, Galderma, Merz Pharma, DAEWOONG, Ipsen and Pfizer, etc.
The global Botulinum Toxin Type A market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ALLERGAN
Galderma
Merz Pharma
DAEWOONG
Ipsen
Pfizer
Global Botulinum Toxin Type A market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Botulinum Toxin Type A market, Segment by Type:
50 Units
100 Units
200 Units
Global Botulinum Toxin Type A market, by Application
Cosmetic Applications
Therapeutic Applications
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Botulinum Toxin Type A manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Botulinum Toxin Type A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Botulinum Toxin Type A Market Overview
1.1 Botulinum Toxin Type A Product Overview
1.2 Botulinum Toxin Type A Market Segment by Type
1.2.1 50 Units
1.2.2 100 Units
1.2.3 200 Units
1.3 Global Botulinum Toxin Type A Market Size by Type
1.3.1 Global Botulinum Toxin Type A Market Size Overview by Type (2018-2029)
1.3.2 Global Botulinum Toxin Type A Historic Market Size Review by Type (2018-2023)
1.3.3 Global Botulinum Toxin Type A Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Botulinum Toxin Type A Sales Breakdown by Type (2018-2023)
1.4.2 Europe Botulinum Toxin Type A Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Botulinum Toxin Type A Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Botulinum Toxin Type A Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Botulinum Toxin Type A Sales Breakdown by Type (2018-2023)
2 Global Botulinum Toxin Type A Market Competition by Company
2.1 Global Top Players by Botulinum Toxin Type A Sales (2018-2023)
2.2 Global Top Players by Botulinum Toxin Type A Revenue (2018-2023)
2.3 Global Top Players by Botulinum Toxin Type A Price (2018-2023)
2.4 Global Top Manufacturers Botulinum Toxin Type A Manufacturing Base Distribution, Sales Area, Product Type
2.5 Botulinum Toxin Type A Market Competitive Situation and Trends
2.5.1 Botulinum Toxin Type A Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Botulinum Toxin Type A Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Botulinum Toxin Type A as of 2022)
2.7 Date of Key Manufacturers Enter into Botulinum Toxin Type A Market
2.8 Key Manufacturers Botulinum Toxin Type A Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Botulinum Toxin Type A Status and Outlook by Region
3.1 Global Botulinum Toxin Type A Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Botulinum Toxin Type A Historic Market Size by Region
3.2.1 Global Botulinum Toxin Type A Sales in Volume by Region (2018-2023)
3.2.2 Global Botulinum Toxin Type A Sales in Value by Region (2018-2023)
3.2.3 Global Botulinum Toxin Type A Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Botulinum Toxin Type A Forecasted Market Size by Region
3.3.1 Global Botulinum Toxin Type A Sales in Volume by Region (2024-2029)
3.3.2 Global Botulinum Toxin Type A Sales in Value by Region (2024-2029)
3.3.3 Global Botulinum Toxin Type A Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Botulinum Toxin Type A by Application
4.1 Botulinum Toxin Type A Market Segment by Application
4.1.1 Cosmetic Applications
4.1.2 Therapeutic Applications
4.1.3 Others
4.2 Global Botulinum Toxin Type A Market Size by Application
4.2.1 Global Botulinum Toxin Type A Market Size Overview by Application (2018-2029)
4.2.2 Global Botulinum Toxin Type A Historic Market Size Review by Application (2018-2023)
4.2.3 Global Botulinum Toxin Type A Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Botulinum Toxin Type A Sales Breakdown by Application (2018-2023)
4.3.2 Europe Botulinum Toxin Type A Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Botulinum Toxin Type A Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Botulinum Toxin Type A Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Botulinum Toxin Type A Sales Breakdown by Application (2018-2023)
5 North America Botulinum Toxin Type A by Country
5.1 North America Botulinum Toxin Type A Historic Market Size by Country
5.1.1 North America Botulinum Toxin Type A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Botulinum Toxin Type A Sales in Volume by Country (2018-2023)
5.1.3 North America Botulinum Toxin Type A Sales in Value by Country (2018-2023)
5.2 North America Botulinum Toxin Type A Forecasted Market Size by Country
5.2.1 North America Botulinum Toxin Type A Sales in Volume by Country (2024-2029)
5.2.2 North America Botulinum Toxin Type A Sales in Value by Country (2024-2029)
6 Europe Botulinum Toxin Type A by Country
6.1 Europe Botulinum Toxin Type A Historic Market Size by Country
6.1.1 Europe Botulinum Toxin Type A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Botulinum Toxin Type A Sales in Volume by Country (2018-2023)
6.1.3 Europe Botulinum Toxin Type A Sales in Value by Country (2018-2023)
6.2 Europe Botulinum Toxin Type A Forecasted Market Size by Country
6.2.1 Europe Botulinum Toxin Type A Sales in Volume by Country (2024-2029)
6.2.2 Europe Botulinum Toxin Type A Sales in Value by Country (2024-2029)
7 Asia-Pacific Botulinum Toxin Type A by Region
7.1 Asia-Pacific Botulinum Toxin Type A Historic Market Size by Region
7.1.1 Asia-Pacific Botulinum Toxin Type A Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Botulinum Toxin Type A Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Botulinum Toxin Type A Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Botulinum Toxin Type A Forecasted Market Size by Region
7.2.1 Asia-Pacific Botulinum Toxin Type A Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Botulinum Toxin Type A Sales in Value by Region (2024-2029)
8 Latin America Botulinum Toxin Type A by Country
8.1 Latin America Botulinum Toxin Type A Historic Market Size by Country
8.1.1 Latin America Botulinum Toxin Type A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Botulinum Toxin Type A Sales in Volume by Country (2018-2023)
8.1.3 Latin America Botulinum Toxin Type A Sales in Value by Country (2018-2023)
8.2 Latin America Botulinum Toxin Type A Forecasted Market Size by Country
8.2.1 Latin America Botulinum Toxin Type A Sales in Volume by Country (2024-2029)
8.2.2 Latin America Botulinum Toxin Type A Sales in Value by Country (2024-2029)
9 Middle East and Africa Botulinum Toxin Type A by Country
9.1 Middle East and Africa Botulinum Toxin Type A Historic Market Size by Country
9.1.1 Middle East and Africa Botulinum Toxin Type A Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Botulinum Toxin Type A Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Botulinum Toxin Type A Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Botulinum Toxin Type A Forecasted Market Size by Country
9.2.1 Middle East and Africa Botulinum Toxin Type A Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Botulinum Toxin Type A Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 ALLERGAN
10.1.1 ALLERGAN Company Information
10.1.2 ALLERGAN Introduction and Business Overview
10.1.3 ALLERGAN Botulinum Toxin Type A Sales, Revenue and Gross Margin (2018-2023)
10.1.4 ALLERGAN Botulinum Toxin Type A Products Offered
10.1.5 ALLERGAN Recent Development
10.2 Galderma
10.2.1 Galderma Company Information
10.2.2 Galderma Introduction and Business Overview
10.2.3 Galderma Botulinum Toxin Type A Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Galderma Botulinum Toxin Type A Products Offered
10.2.5 Galderma Recent Development
10.3 Merz Pharma
10.3.1 Merz Pharma Company Information
10.3.2 Merz Pharma Introduction and Business Overview
10.3.3 Merz Pharma Botulinum Toxin Type A Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merz Pharma Botulinum Toxin Type A Products Offered
10.3.5 Merz Pharma Recent Development
10.4 DAEWOONG
10.4.1 DAEWOONG Company Information
10.4.2 DAEWOONG Introduction and Business Overview
10.4.3 DAEWOONG Botulinum Toxin Type A Sales, Revenue and Gross Margin (2018-2023)
10.4.4 DAEWOONG Botulinum Toxin Type A Products Offered
10.4.5 DAEWOONG Recent Development
10.5 Ipsen
10.5.1 Ipsen Company Information
10.5.2 Ipsen Introduction and Business Overview
10.5.3 Ipsen Botulinum Toxin Type A Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ipsen Botulinum Toxin Type A Products Offered
10.5.5 Ipsen Recent Development
10.6 Pfizer
10.6.1 Pfizer Company Information
10.6.2 Pfizer Introduction and Business Overview
10.6.3 Pfizer Botulinum Toxin Type A Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Pfizer Botulinum Toxin Type A Products Offered
10.6.5 Pfizer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Botulinum Toxin Type A Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Botulinum Toxin Type A Industrial Chain Analysis
11.4 Botulinum Toxin Type A Market Dynamics
11.4.1 Botulinum Toxin Type A Industry Trends
11.4.2 Botulinum Toxin Type A Market Drivers
11.4.3 Botulinum Toxin Type A Market Challenges
11.4.4 Botulinum Toxin Type A Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Botulinum Toxin Type A Distributors
12.3 Botulinum Toxin Type A Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Food & Beverages Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
